NCT07140328

Evaluation of the Safety and Efficacy of HSK39004 Dry Powder Inhaler and HSK39004 Inhalation Suspension in Chinese Patients With Chronic Obstructive Pulmonary Disease (COPD)

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2025-04-24Est. Completion: 2025-07-10

Enrollment target: 50 participants

Locations

Contact

Hospital Acquired Pneumonia (HAP)Cardiovascular and Respiratory Disease

The HOMI-LUNG - HAP study is part of the HOMI-LUNG project, funded by the Horizon Europe program. The "HOMI-LUNG" projec…

Angers, FranceEst. completion Jul 3, 2028

RSV

The purpose of this pragmatic randomized trial is to evaluate the vaccine effectiveness of bivalent RSV prefusion F vacc…

Copenhagen, DenmarkEst. completion May 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.